India's Pharmaceutical Exports

Country Profile

Costa Rica

Costa Rica is an emerging destination for Indian pharmaceutical exports — $37.9M in FY 2025–26, with 2.9× growth over the past decade. Medicines accounts for 72% of shipments, with vaccines contributing $340K. The compound annual growth rate since FY2015 stands at 10.3%.

🇨🇷 $37.9M · 2.9× growth since FY2015 · 10.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$37.9M
Exports FY2025–26 DGCIS
2.9×
Growth FY2015→2026
10.3%
CAGR FY2015→2026
72%
Medicines Share
5
Product Categories Supplied
Costa Rica is an emerging destination for Indian pharmaceutical exports — $37.9M in FY 2025–26, with 2.9× growth over the past decade. Medicines accounts for 72% of shipments, with vaccines contributing $340K. The compound annual growth rate since FY2015 stands at 10.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $27.3M (72.0%) Medicine Ingredients $8.66M (22.9%) Traditional & Herbal $967K (2.6%) Surgical & Hospital Supplies $637K (1.7%) Vaccines $340K (0.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Costa Rica in the RBI overseas direct investment dataset (2011–2026).